Medtronic to Present on AI and QMSR at June Medtech Trials Conference
Medtronic will present at the Outsourcing in Clinical Trials: Medical Devices USA 2026 conference in Minneapolis on June 2–3, joining speakers from Phillips and others to explore lean trial protocols, decentralized elements and digital workflows focused on participant experience. Sessions will also cover AI integration, FDA’s QMSR transition challenges and real-world evidence guidance.
1. Conference Overview
The Outsourcing in Clinical Trials: Medical Devices USA 2026 conference takes place June 2–3 in Minneapolis and will bring together industry leaders to discuss operational and regulatory developments in medical device trials. Attendees include senior executives from Medtronic, Phillips, Agitated Solutions and other specialty site networks.
2. Medtronic’s Role
Medtronic’s session will cover implementation of lean trial protocols, incorporation of decentralized elements and digital workflows designed to enhance participant experience. The company will share best practices alongside a fireside chat on consent processes and comprehension.
3. Key Industry Themes
Key themes include artificial intelligence integration in trial operations, strategies for navigating the FDA’s new Quality Management System Regulation (QMSR), and leveraging real-world evidence guidance to design fit-for-purpose clinical studies. Panels will also address funding landscape shifts and collaborative research strategies.